These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8856388)

  • 1. Serotonin--one possible link between oxygen metabolism and the regulation of blood flow in the brain?
    Gustafsson U; Sjöberg F
    Int J Microcirc Clin Exp; 1996; 16(3):143-6. PubMed ID: 8856388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin as a modulator of skeletal muscle oxygenation: effects of ketanserin and ritanserin on oxygen pressure distributions.
    Thorborg P; Lund N
    Int J Microcirc Clin Exp; 1989 Apr; 8(2):191-203. PubMed ID: 2499554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hyperoxemia and ritanserin on skeletal muscle microflow.
    Thorborg P; Gustafsson U; Sjöberg F; Harrison DK; Lewis DH
    J Appl Physiol (1985); 1990 Apr; 68(4):1494-500. PubMed ID: 2112127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical spreading depression-associated hyperemia in rats: involvement of serotonin.
    Gold L; Back T; Arnold G; Dreier J; Einhäupl KM; Reuter U; Dirnagl U
    Brain Res; 1998 Feb; 783(2):188-93. PubMed ID: 9507121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ritanserin, a 5-HT2 receptor antagonist, on ischemic cerebral blood flow and infarct volume in rat middle cerebral artery occlusion.
    Takagi K; Ginsberg MD; Globus MY; Busto R; Dietrich WD
    Stroke; 1994 Feb; 25(2):481-5; discussion 485-6. PubMed ID: 8303760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle capillary flow and oxygenation in hypoxic hypoxia: effect of a 5-HT2 receptor antagonist.
    Gustafsson U; Lewis DH; Thorborg P
    Adv Exp Med Biol; 1992; 317():759-64. PubMed ID: 1288201
    [No Abstract]   [Full Text] [Related]  

  • 7. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
    Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors.
    Ashby CR; Edwards E; Wang RY
    Synapse; 1992 Jan; 10(1):7-15. PubMed ID: 1536032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice.
    Matsumoto K; Mizowaki M; Thongpraditchote S; Murakami Y; Watanabe H
    Pharmacol Biochem Behav; 1997 Mar; 56(3):417-22. PubMed ID: 9077577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the 5-HT2 receptor antagonist, ritanserin on hyperthermia and depletion of 5-HT in frontal cortex induced by a 5-HT releasing drug, p-chloroamphetamine (PCA) in mice.
    Yamada J; Sugimoto Y; Ohkura M; Inoue K
    Biol Pharm Bull; 2001 Oct; 24(10):1195-7. PubMed ID: 11642332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 5-HT(2A) receptor antagonists on blood flow in the carotid vessels upon elevation of serotonin level.
    Yakovlev DS; Spasov AA; Mal'tsev DV; Anisimova VA
    Bull Exp Biol Med; 2014 Jul; 157(3):350-2. PubMed ID: 25070162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients.
    Wappler F; Scholz J; Oppermann S; von Richthofen V; Steinfath M; Schulte am Esch J
    J Clin Anesth; 1997 Jun; 9(4):306-11. PubMed ID: 9195354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia.
    Löscher W; Witte U; Fredow G; Ganter M; Bickhardt K
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):483-93. PubMed ID: 2118235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.
    de Mello Cruz AP; Pinheiro G; Alves SH; Ferreira G; Mendes M; Faria L; Macedo CE; Motta V; Landeira-Fernandez J
    Psychopharmacology (Berl); 2005 Nov; 182(3):345-54. PubMed ID: 16133141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediation of 5-HT-induced internal carotid vasodilatation in GR127935- and ritanserin-pretreated dogs by 5-HT7 receptors.
    Centurión D; Sánchez-López A; Ortiz MI; De Vries P; Saxena PR; Villalón CM
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):169-76. PubMed ID: 10961380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hypoxic hypoxia and ritanserin on capillary flow and oxygenation in rabbit skeletal muscle.
    Gustafsson U; Sjöberg F; Lewis DH; Thorborg P
    Acta Physiol Scand; 1994 Jan; 150(1):39-45. PubMed ID: 8135122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the 5-HT2 receptor antagonist ritanserin on halothane-induced increase of inositol phosphates in porcine malignant hyperthermia.
    Richter A; Scholz J; Löscher W; Tonner PH; Wappler F
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):593-7. PubMed ID: 8938657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
    Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ritanserin, a 5-HT2 receptor antagonist, increases subcortical blood flow following photothrombotic middle cerebral artery occlusion in rats.
    Back T; Prado R; Zhao W; Watson BD; Ginsberg MD
    Neurol Res; 1998 Oct; 20(7):643-7. PubMed ID: 9785594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex.
    Pehek EA
    Synapse; 1996 Sep; 24(1):12-8. PubMed ID: 9046072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.